BofA analyst Matthew DeYoe upgraded Chemours to Buy from Neutral with a price target of $40, up from $37.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CC: